Press release
Antibacterial Drugs Market - Global Industry Insights, Trends and Opportunity Analysis, 2016 - 2024
Prevalence of bacterial infections and diseases is especially high in third world countries and significantly hampers quality of life across the globe. Further adding to the woes of the affected population is the increasing strains of bacteria that are resistant to conventional antibacterial drugs. The epidemic of antibacterial resistance has spurred interest among the global healthcare organizations and a few pharmaceutical companies and research institutes to develop next-generation antibacterial drugs to effectively thwart such maladies. Unregulated and over prescription of antibacterial drugs has led to increased drug resistance. Moreover, genetic mutations are considered to be another major reason for antibacterial drug resistance. Ironically, these factors have greatly constrained the growth of antibacterial drugs market for years.
Invention of Penicillin was a major breakthrough for treating bacterial infections. This stimulated research for more antibacterial drugs to treat different bacteria such as Escherichia coli, Klebsiella pneumonia, Staphylococcus aureus (MRSA) and Enterococcus species. However, price control and decreasing financial incentives discouraged pharmaceutical companies to conduct further research in this field.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/177
The timeline highlights the large void in introduction of new antibacterial drugs during period 1960–2000. Streptomycin, sulfonamide, macrolide, nalidixic cid, aminoglycoside, tetracycline, and linezolid are among the bacterial resistant drugs.
Prospective drug candidates in research to improve the future outlook of the global antibacterial drugs market
The global antibacterial drugs market potential is estimated based on the current antibacterial drug classes, including those mentioned above and those in clinical trials. As of March 2016, there are around 37 drugs in clinical development for treating serious bacterial infections. These drugs are intended to be primarily launched in the U.S.
Moreover, FDA is encouraging development of new antibacterial drugs by laying out guidelines for the industry on the types of clinical studies to be conducted on antibacterial drug evaluation. This factor coupled with various incentives for research companies would create a positive outlook for the global antibacterial drugs resistance market in the near future.
Also, in March 2017, the WHO released a list of pathogens, classified based on the criticality/urgency, for which newer antibacterial drugs are required. The different environmental forces working towards development of newer antibacterial drugs would be a major continuing factor for the global antibacterial drugs market growth.
Alarming rise in drug resistant strains of bacteria driving awareness initiatives and programs by global healthcare organizations to back companies in the antibacterial drugs market
According to the Centers for Drug Disease Prevention and Control (CDC), every year at least 2 million people in the U.S. acquire bacterial infections that are resistant to drugs. Antibacterial resistance results in 23,000 deaths every year in the U.S. Moreover, according to the European Antimicrobial Resistance Surveillance Network (EARS-Net) data of November 2016, antibiotic resistance is higher in southern and south-eastern Europe than in northern Europe.
Multiple drug resistance, as in case of tuberculosis, has further aggravated the treatment for specific conditions. According to the World health Organization (WHO), India has the highest burden of TB worldwide. Furthermore, the MDR-TB cases resistant to second-line drugs was 16% among already treated cases reported in 2015. Globally, an estimated 480,000 people developed MDR-TB in 2015 (WHO). The Government of India has drafted a national Strategic Plan 2017-2025 for eradicating TB in India. This would further propel the antibacterial drugs market in India.
The WHO has carved a ‘Global Action Plan on Antimicrobial Resistance’ in 2015 to fight against growing antibacterial resistance. CDC is also working in close collaboration with healthcare providers, pharmaceuticals companies, farmers, agriculture and environmental specialists, and representatives from Federal agencies to monitor, and control the prescription and use of antibacterial drugs. Such initiatives are expected to hold drugs for the future generation until the new drug launch and thus drive the antibacterial drugs market.
Some of the major players in the global antibacterial drugs market are Pfizer, Inc., Johnson & Johnson, AstraZeneca plc, F. Hoffmann-La Roche AG, Merck & Co., Inc., Evotec Pharmaceuticals, Allecra Therapeutics, Kyorin Pharmaceutical, and Allergan plc.
To know more about the Antibacterial drugs Market, click the link below, https://www.coherentmarketinsights.com/ongoing-insight/antibacterial-drugs-market-177
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
CONTACT US:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel : +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibacterial Drugs Market - Global Industry Insights, Trends and Opportunity Analysis, 2016 - 2024 here
News-ID: 591768 • Views: …
More Releases from CMI - Pharmaceutical Research Report
Familial Amyloid Cardiomyopathy Treatment Market - Outlook, and Opportunity Anal …
Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy is also known as hereditary cardiac transthyretin amyloidosis or hereditary amyloid cardiomyopathy. The protein transthyretin amyloid fibrils infiltrate the myocardium that leads to diastolic dysfunction from restrictive cardiomyopathy, which eventually result to heart failure. There are several mutation in TTR which are associated…
Hutchinson-Gilford Progeria Treatment Market - Global Industry Insights, Trends, …
Hutchinson-Gilford progeria syndrome is a genetic condition characterized by the dramatic, rapid, appearance of aging from the childhood. Hutchinson-Gilford progeria syndrome is caused by a mutation in the lamin A (LMNA) gene. The affected children develop a characteristic facial experience including prominent eyes, small chin, protruding ears, thin lips and a thin nose with a beaked tip. This syndrome also causes hair loss (alopecia), joint abnormalities, aged-looking skin, and a…
Sterile Injectable Market to Breach US$ 540 Billion Level by 2024, As Pharma Gia …
The Global Sterile Injectables Market was valued at US$ 299.7 billion in 2015 and is projected to expand at a CAGR of 6.9% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights.
According to Piramal Enterprises Ltd. there are 2,400 sterile injectable products are under development phase, which would lead to introduction of advanced products in the global sterile injectables market. Generic market is,…
More Releases for Antibacterial
Product Innovations In The Antibacterial Products Market Industry Trends Gaining …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Antibacterial Products Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for antibacterial products has witnessed a consistent growth over the past few years. A rise from $44.29 billion in 2024 to $46.38 billion in 2025 is expected, representing a compound annual growth rate (CAGR) of 4.7%. Factors…
Evolving Market Trends In The Antibacterial Products Industry: Product Innovatio …
The Antibacterial Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Antibacterial Products Market Size During the Forecast Period?
In recent times, there has been a steady growth in the market size of antibacterial products. A compound annual growth rate (CAGR) of…
Antibacterial Washcloth Market Size 2024 to 2031.
Market Overview and Report Coverage
An Antibacterial Washcloth is a type of washcloth that is designed to effectively kill bacteria and prevent the spread of germs during daily hygiene routines. These washcloths are commonly used in hospitals, nursing homes, and households to maintain cleanliness and reduce the risk of infection.
The current outlook for the Antibacterial Washcloth Market is optimistic, with a projected growth rate of 10.20% during the forecasted…
Antibacterial Polyurethane Systems for Filter Production
RAMPF Group, Inc. is presenting high-performance antibacterial sealing foams and casting resins based on polyurethane for filter production at AHR Expo 2023 in Atlanta, GA, from February 6 to 8 - Building C, Level 1 / C7011.
Antibacterial polyurethane systems developed by RAMPF Group, Inc. are used by leading manufacturers worldwide to seal and cast filters and filter components in heating, ventilation, and air conditioning systems (HVAC). The company's product portfolio…
Antibacterial Masks Market 2021 | Detailed Report
Global Antibacterial Masks Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures)…
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an…
